|
Hjelmesaet J, Åsberg A, Hartmann A, Jenssen T. New-onset diabetes mellitus after renal transplantation: diagnosis and treatment
Int Diabetes Monitor 5(17):15-21, 2005
Lemahieu WPD, Hermann M, Åsberg A, Verbeke K, Holdaas H, Vanrenterghem Y, Maes BD. Combined therapy with atorvastatin and calcineurin inhibitors: No interaction with tacrolimus
Am J Transplant
5:2236-2243, 2005
Hermann M, Åsberg A, Christensen H, Reubsaet JLE, Holdaas H, Hartmann A. Atorvastatin does not affect pharmacokinetics of cyclosporine in renal transplant recipients
Eur J Clin Pharmacol
61:59-62, 2005
Voytovich MH, Simonsen C, Jenssen T, Åsberg A, Midtvedt K, Hjelmesaeth J, Hartmann A. Short term treatment with rosiglitazone improves glucose disposal rate and endothelial function in renal transplant recipients with glucose intolerance
Nephrol Dial Transplant
20:413-418, 2005
Hjelmesaeth J, Åsberg A, Müller F, Jenssen T, Hartmann A. New-onset posttransplantation diabetes mellitus: Insulin resistance or insulinopenia Impact of immunosuppressive drugs, hepatitis C virus and cytomegalovirus infection
Current Diabetes Reviews
1(1):1-10, 2005
Hermann M, Åsberg A, Christensen H, Holdaas H, Hartmann A, Reubsaet JLE. Substantially elevated levels of atorvastatin and metabolites in cyclosporine A treated renal transplant recipients
Clin Pharm Ther
76(4):388-391, 2004
Åsberg, A and Holdaas H Fluvastatin and fluvastatin extended release: a clinical and safety profile
Expert Rev Cardiovasc Ther
2(5):641-652, 2004
Sagedal S, Nordal KP, Hartmann A, Midtvedt K, Foss A, Åsberg A, Degré M, Fauchald P, Rollag H. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomised, comparative study
Nephrol Dial Transplant
18(9):1899-1908, 2003
Dr. A Asberg
Dirección profesional:
Sem Sælandsvei 3, P.O.Box 1068 Blindern, 0316 Oslo, Noruega
|
